(Q42777103)

7 November 2017

Treatment with marine collagen peptides modulates glucose and lipid metabolism in Chinese patients with type 2 diabetes mellitus (English)

1 reference

7 November 2017

1 reference

Cui-Feng Zhu

1

1 reference

7 November 2017

Guan-Zhi Li

2

1 reference

7 November 2017

Hong-Bin Peng

3

1 reference

7 November 2017

Fan Zhang

4

1 reference

7 November 2017

Yun Chen

5

1 reference

7 November 2017

Yong Li

6

1 reference

7 November 2017

1 December 2010

1 reference

Applied Physiology, Nutrition, and Metabolism

7 November 2017

1 reference

7 November 2017

35

1 reference

7 November 2017

6

1 reference

7 November 2017

797-804

1 reference

Optimal medical treatment of cardiovascular risk factors: can we prevent the development of heart failure?

7 November 2017

1 reference

Bioactive peptides from marine sources: pharmacological properties and isolation procedures

21 January 2018

1 reference

Clinical outcomes in metabolic syndrome

21 January 2018

1 reference

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

Intramuscular lipid metabolism, insulin action, and obesity

21 January 2018

1 reference

Diagnosis and management of type 2 diabetes

21 January 2018

1 reference

Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study

21 January 2018

1 reference

Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China

21 January 2018

1 reference

Molecular basis of selective PPARgamma modulation for the treatment of Type 2 diabetes

21 January 2018

1 reference

Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert cons

21 January 2018

1 reference

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

21 January 2018

1 reference

Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition

21 January 2018

1 reference

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus

21 January 2018

1 reference

Dietary modulation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms

21 January 2018

1 reference

Type 2 diabetes mellitus: prevention of macrovascular complications.

21 January 2018

1 reference

Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease

21 January 2018

1 reference

Skin peptides: biological activity and therapeutic opportunities.

21 January 2018

1 reference

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

21 January 2018

1 reference

Adipocytokines and the metabolic complications of obesity

21 January 2018

1 reference

Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions

21 January 2018

1 reference

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

The importance of free fatty acids in the development of Type 2 diabetes.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/H10-075

1 reference

7 November 2017

1 reference